Author Archive: Jeremy Parkinson

Q4 GDP Advance Estimate: Real GDP At 2.6%

Q4 GDP Advance Estimate: Real GDP At 2.6%

The Advance Estimate for Q4 GDP, to one decimal, came in at 2.6% (2.55% to two decimal places), a decrease over 3.2% for the Q3 Third Estimate. Investing.com had a consensus of 3.0%. Here is the slightly abbreviated opening text from the Bureau of Economic Analysis news release: Real gross domestic product (GDP) increased at an annual […]
Gold Upleg Breaking Out

Gold Upleg Breaking Out

Gold’s strong upleg accelerated this week, powering to major new breakout highs. Speculators rushed to buy gold futures following surprising weak-dollar comments from the US Treasury Secretary, which hit the US dollar hard. That boosted gold to critical technical levels that should really intensify the shift back to bullish psychology. This mounting gold breakout confirms […]
Billion Dollar Unicorns: Is The Duopoly Keeping AppNexus From Listing?

Billion Dollar Unicorns: Is The Duopoly Keeping AppNexus From Listing?

According to eMarketer, the US programmatic digital display ad spending was estimated to grow from $32.56 billion in 2017  to grow to $45.72 billion by 2019. The growth will be driven by continued emphasis on advertising quality and brand safety. Billion Dollar Unicorn player AppNexus is hoping to cash in on this growth, if it can address the competition from […]
BEA Estimates 4th Quarter 2017 GDP Growth To Be 2.54%

BEA Estimates 4th Quarter 2017 GDP Growth To Be 2.54%

In their first (and preliminary) estimate of the US GDP for the fourth quarter of 2017, the Bureau of Economic Analysis (BEA) reported that the US economy was growing at a +2.54% annual rate, down -0.62% from the prior quarter.  This is a report of sharp contrasts. Although the headline number is down relative to the prior […]
Bed Bath & Beyond Sinks After Analyst Says Sell With Competition Rising

Bed Bath & Beyond Sinks After Analyst Says Sell With Competition Rising

Shares of Bed Bath & Beyond (BBBY) dropped in morning trading after an analyst downgraded the stock to his firm’s equivalent of a Sell rating, citing concerns over the growth and margin outlook relative to peers. ANALYST TURNS BEARISH: JPMorgan analyst Christopher Horvers downgraded Bed Bath & Beyond to Underweight, his firm’s equivalent of a […]
Is Schwab Small-Cap Equity A Strong Mutual Fund Pick Right Now?

Is Schwab Small-Cap Equity A Strong Mutual Fund Pick Right Now?

There are plenty of choices in the Small Cap Growth category, but where should you start your research? Well, one fund that might be worth investigating is Schwab Small-Cap Equity (SWSCX – Free Report). SWSCX possesses a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on nine forecasting factors like size, cost, and past […]
Week In Review: Central Banks And Davos Dominate

Week In Review: Central Banks And Davos Dominate

This week, the focus among the financial community was on the United States corporate earnings, Monetary Policy decisions from Japan and ECB, and the ongoing meeting in Davos, Switzerland. Corporate Earnings This week, we received major earnings from top companies like Caterpillar, 3M, Starbucks, AbbVie, Haliburton, and Netflix. Among the top movers were Netflix, which […]
E
                                                
                        Moving Averages In Extended Market Climates Part Two – The Countdown Clock

E Moving Averages In Extended Market Climates Part Two – The Countdown Clock

In Part one I talked a lot about Moving Averages in extended market climates such as the one we are currently in. Hence: There comes a time where markets get extended away from the 50-day average. That’s where shorter-term moving averages come into play.  Keep in mind when dealing with the 10 and 20-day averages they are what I […]
Will Intel Follow Microsoft?

Will Intel Follow Microsoft?

Well, all that hoo-ha a couple of weeks ago about the Intel bug turned out to be meaningless, didn’t it? INTC is roaring almost 10% higher right now. What’s more astonishing to me is that Intel was more expensive 18 years ago than it is right now! It has been struggling to complete this pattern for almost […]
AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up

AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up

AbbVie Inc. ABBV reported impressive results in the fourth quarter of 2017. The company surpassed earnings and revenue estimates during the period. Importantly, it raised its earnings expectations for 2018.  AbbVie’s shares have soared 90.1% in a year’s time, significantly outperforming the industry’s 26.5% rally. The biopharmaceutical company reported fourth-quarter 2017 earnings of $1.48 per share, beating the […]